Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced successful in vitro analyses of gynecological samples collected utilizing its new Hygee medical device. Hygee is a discreet, wearable medical device for women to anonymously test for sexually transmitted infections, with collected samples tested by Procréa. According to the update, pre-launch results identified the presence of Chlamydia in test subjects, confirming earlier testing in more than 500 women. “Hygee is an incredible innovation, and we have partners from many countries waiting to market the device,” ETST CEO and Chief Scientific Officer Dr. Michel Aubé stated in the news release. “This is only the beginning of realizing the potential of this unique device, and we look forward to updating our shareholders on our progress.”
To view the full press release, visit http://cnw.fm/K6ePv
About Earth Science Tech, Inc.
Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition to studies through DV Biologics that prove the company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com